Qingxiang Guan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qingxiang Guan has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Xinying Wang
School of Pharmaceutical Sciences Jilin University Changchun Jilin China
8 shared publicationsGuangyuan Zhang
Department of Pharmaceutics, School of Pharmacy, Jilin University, Changchun, China
5 shared publicationsLinlin Lv
School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China
5 shared publicationsDi Yu
School of Pharmacy Jilin University Changchun PR China
4 shared publicationsJi Wu
Department of Pharmaceutics, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun 130021, China
4 shared publicationsLong Huang
School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China
4 shared publications
Latest Publications
- 9 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71588
Enhanced Activity of Eugenol Pickering Emulsion Using Lactoferrin‐Chlorogenic Acid Complex as a Green Stabilizer
Exploiting natural and bioactive stabilizers to fabricate green emulsions has attracted increasing attention. In this work, lactoferrin (LF) was combined with chlorogenic acid (CGA) to construct the LF‐CGA complex to prepare a eugenol (EG) Pickering emulsion (ELC/PE). The surface activity and binding mechanism of LF‐CGA were explored. Additionally, the antioxidant, antibacterial, and anti‐inflammatory capacities of ELC/PE were compared. The contact angle of LF‐CGA approached 90° (81.9°), indicating enhanced stability at the oil‐water interface. The interaction between LF and CGA was primarily driven by static quenching and hydrogen bonding. The ELC/PE consisted of 1.5 wt% LF‐CGA, with distilled water and EG as the aqueous and oil phases (15:1 v/v, aqueous/oil). The DPPH − , O 2 − , and ABTS + scavenging rates of ELC/PE were 86.3%, 75.3%, and 83.4%, respectively. The ELC/PE displayed superior antibacterial ability, along with inhibition rates of 99.0% and 99.5% against Candida albicans and Staphylococcus aureus , respectively. Additionally, the ELC/PE exhibited the most significant suppression of ear swelling (81.8%), confirming its anti‐inflammatory ability. These values were the highest among all experimental groups. The LF‐CGA complex acts as an emulsifier to enhance EG bioactivities. This novel complex holds great potential for expanding the practical applications of poorly soluble bioactive compounds.
- 9 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71588
Enhanced Activity of Eugenol Pickering Emulsion Using Lactoferrin‐Chlorogenic Acid Complex as a Green Stabilizer
Exploiting natural and bioactive stabilizers to fabricate green emulsions has attracted increasing attention. In this work, lactoferrin (LF) was combined with chlorogenic acid (CGA) to construct the LF‐CGA complex to prepare a eugenol (EG) Pickering emulsion (ELC/PE). The surface activity and binding mechanism of LF‐CGA were explored. Additionally, the antioxidant, antibacterial, and anti‐inflammatory capacities of ELC/PE were compared. The contact angle of LF‐CGA approached 90° (81.9°), indicating enhanced stability at the oil‐water interface. The interaction between LF and CGA was primarily driven by static quenching and hydrogen bonding. The ELC/PE consisted of 1.5 wt% LF‐CGA, with distilled water and EG as the aqueous and oil phases (15:1 v/v, aqueous/oil). The DPPH − , O 2 − , and ABTS + scavenging rates of ELC/PE were 86.3%, 75.3%, and 83.4%, respectively. The ELC/PE displayed superior antibacterial ability, along with inhibition rates of 99.0% and 99.5% against Candida albicans and Staphylococcus aureus , respectively. Additionally, the ELC/PE exhibited the most significant suppression of ear swelling (81.8%), confirming its anti‐inflammatory ability. These values were the highest among all experimental groups. The LF‐CGA complex acts as an emulsifier to enhance EG bioactivities. This novel complex holds great potential for expanding the practical applications of poorly soluble bioactive compounds.
- 13 May 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 312, 144219
Fabrication of Bletilla Striata polysaccharide-Fe (III) complex and its anti-iron deficiency anemia effects
- 13 May 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 312, 144219
Fabrication of Bletilla Striata polysaccharide-Fe (III) complex and its anti-iron deficiency anemia effects
- 12 May 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (12) , 1495-1511
Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy
Glioblastoma (GBM) poses a formidable challenge because of its high morbidity and mortality. The therapeutic efficacy of GBM is significantly hampered by the intricate blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB). Nanomaterial-based brain-targeted delivery systems have shown great potential for effectively delivering therapeutic agents for GBM treatment by overcoming the limitations of conventional drugs, such as poor BBB penetration, a short half-life, and low bioavailability. This review focuses on an in-depth analysis of the interplay between the BBB/BBTB and drug transport kinetics while analyzing innovative nanoparticle-mediated strategies for enhanced GBM treatment. Moreover, the delivery strategies of nanoparticle-based brain-targeted systems are emphasized, with particular attention given to biomimetic nanoparticles (BMNPs), whose unique advantages. The current challenges, translational potential, and future research directions in this rapidly evolving field are comprehensively discussed, highlighting advances in nanomaterial applications. This review aims to stimulate further research into GBM delivery systems, offering promising avenues for maximizing the therapeutic effects of gene drugs or chemotherapeutic agents in practical applications.
- 12 May 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (12) , 1495-1511
Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy
Glioblastoma (GBM) poses a formidable challenge because of its high morbidity and mortality. The therapeutic efficacy of GBM is significantly hampered by the intricate blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB). Nanomaterial-based brain-targeted delivery systems have shown great potential for effectively delivering therapeutic agents for GBM treatment by overcoming the limitations of conventional drugs, such as poor BBB penetration, a short half-life, and low bioavailability. This review focuses on an in-depth analysis of the interplay between the BBB/BBTB and drug transport kinetics while analyzing innovative nanoparticle-mediated strategies for enhanced GBM treatment. Moreover, the delivery strategies of nanoparticle-based brain-targeted systems are emphasized, with particular attention given to biomimetic nanoparticles (BMNPs), whose unique advantages. The current challenges, translational potential, and future research directions in this rapidly evolving field are comprehensively discussed, highlighting advances in nanomaterial applications. This review aims to stimulate further research into GBM delivery systems, offering promising avenues for maximizing the therapeutic effects of gene drugs or chemotherapeutic agents in practical applications.
- Open Access
- 25 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 15
Correction: Zhang et al. Interactions of Self-Assembled Bletilla Striata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles. Pharmaceutics 2019, 11, 43
- 25 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 15
Open AccessCorrection: Zhang et al. Interactions of Self-Assembled Bletilla Striata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles. Pharmaceutics 2019, 11, 43
- 8 August 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 278 (Pt 1) , 134597
Multifunctional nanofibrous scaffolds for enhancing full-thickness wound healing loaded with Bletilla striata polysaccharides
- 8 August 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 278 (Pt 1) , 134597
Multifunctional nanofibrous scaffolds for enhancing full-thickness wound healing loaded with Bletilla striata polysaccharides
- 21 November 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 256 (Pt 2) , 128342
Catechol chitosan coated dual-loaded liposomes based on oxidation and saccharification mechanisms for enhancing skin anti-aging effects
- 21 November 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 256 (Pt 2) , 128342
Catechol chitosan coated dual-loaded liposomes based on oxidation and saccharification mechanisms for enhancing skin anti-aging effects
- 30 July 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 643, 123284
Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression
- 30 July 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 643, 123284
Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression
- 29 December 2022
- Published by Wiley in Phytotherapy Research
- Vol. 37 (5) , 1823-1838
Total saponins of panax ginseng via the CX3CL1/CX3CR1 axis attenuates neuroinflammation and exerted antidepressant‐like effects in chronic unpredictable mild stress in rats
Total saponins of Panax ginseng (TSPG) have antidepressant effects. However, the underlying antidepressant mechanism of TSPG remains not clear. This study aimed to predict the mechanism of TSPG by bioinformatics analysis and to verify it experimentally. Bioinformatics analysis showed that the antidepressant effects of TSPG may be related to inflammation, and CX3CL1/CX3CR1 may play a key mediating role. Wistar rats were exposed to chronic unpredictable mild stress (CUMS) for 6 weeks, and TSPG (50 mg/kg/d, 100 mg/kg/d) was administered throughout the modeling period. It was found that TSPG improves depressive behavior and reduces neuropathic damage in the hippocampus in rats. Meanwhile, TSPG decreased mRNA and protein expression of pro‐inflammatory cytokines and CX3CL1/CX3CR1 and inhibited P38 and JNK protein phosphorylation in the hippocampus. Rat astrocytes were employed to explore further the potential mechanism of TSPG in regulating CX3CL1/CX3CR1. The results showed that CX3CL1 small interfering RNA (siRNA‐CX3CL1) and CX3CR1 inhibitor (JMS‐17‐2) had similar effects to TSPG, that is, reduced inflammatory response, reactive oxygen species (ROS), and phosphorylation of P38 and JNK proteins, while overexpression of CX3CL1 (pcDNA‐CX3CL1) counteracted the above effects of TSPG. It is suggested that the antidepressant effect of TSPG may be achieved through inhibition of CX3CL1/CX3CR1.
- 29 December 2022
- Published by Wiley in Phytotherapy Research
- Vol. 37 (5) , 1823-1838
Total saponins of panax ginseng via the CX3CL1/CX3CR1 axis attenuates neuroinflammation and exerted antidepressant‐like effects in chronic unpredictable mild stress in rats
Total saponins of Panax ginseng (TSPG) have antidepressant effects. However, the underlying antidepressant mechanism of TSPG remains not clear. This study aimed to predict the mechanism of TSPG by bioinformatics analysis and to verify it experimentally. Bioinformatics analysis showed that the antidepressant effects of TSPG may be related to inflammation, and CX3CL1/CX3CR1 may play a key mediating role. Wistar rats were exposed to chronic unpredictable mild stress (CUMS) for 6 weeks, and TSPG (50 mg/kg/d, 100 mg/kg/d) was administered throughout the modeling period. It was found that TSPG improves depressive behavior and reduces neuropathic damage in the hippocampus in rats. Meanwhile, TSPG decreased mRNA and protein expression of pro‐inflammatory cytokines and CX3CL1/CX3CR1 and inhibited P38 and JNK protein phosphorylation in the hippocampus. Rat astrocytes were employed to explore further the potential mechanism of TSPG in regulating CX3CL1/CX3CR1. The results showed that CX3CL1 small interfering RNA (siRNA‐CX3CL1) and CX3CR1 inhibitor (JMS‐17‐2) had similar effects to TSPG, that is, reduced inflammatory response, reactive oxygen species (ROS), and phosphorylation of P38 and JNK proteins, while overexpression of CX3CL1 (pcDNA‐CX3CL1) counteracted the above effects of TSPG. It is suggested that the antidepressant effect of TSPG may be achieved through inhibition of CX3CL1/CX3CR1.
- 1 December 2021
- Published by Elsevier in Phytomedicine
- Vol. 93, 153792
Novel insights into antidepressant mechanism of Kai Xin San formula: Inhibiting NLRP3 inflammasome activation by promoting autophagy
- 1 December 2021
- Published by Elsevier in Phytomedicine
- Vol. 93, 153792
Novel insights into antidepressant mechanism of Kai Xin San formula: Inhibiting NLRP3 inflammasome activation by promoting autophagy
- 29 September 2021
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 38 (5) , 585-597
The interaction of folate-modified Bletilla striata polysaccharide-based micelle with bovine serum albumin
We fabricated an amphiphilic folate-modified Bletilla striata polysaccharide (FA-BSP-SA) copolymer that exhibited good biocompatibility and superior antitumor effects. This study investigated the affinity between FA-BSP-SA and bovine serum albumin (BSA) via multispetroscopic approaches. Changes in the morphology and particle size showed that FA-BSP-SA formed a blurry “protein corona”. Stern–Volmer equation demonstrated that FA-BSP-SA micelles decreased the fluorescence of BSA via static quenching. The measurement results of thermodynamic parameters (entropy change, enthalpy change, and Gibbs free energy) suggested that the binding between FA-BSP-SA and BSA was spontaneous in which Van der Waals forces and hydrogen bonding played major roles. The results from synchronous fluorescence, circular dichroism, and UV spectra also revealed that BSA conformation was slightly altered by decreasing α-helical contents. In addition, the antitumor effects in vitro of Dox@FA-BSP-SA micelles and the cellular uptake behavior of micelles in 4T1 cells were decreased after incubating with BSA.
- 29 September 2021
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 38 (5) , 585-597
The interaction of folate-modified Bletilla striata polysaccharide-based micelle with bovine serum albumin
We fabricated an amphiphilic folate-modified Bletilla striata polysaccharide (FA-BSP-SA) copolymer that exhibited good biocompatibility and superior antitumor effects. This study investigated the affinity between FA-BSP-SA and bovine serum albumin (BSA) via multispetroscopic approaches. Changes in the morphology and particle size showed that FA-BSP-SA formed a blurry “protein corona”. Stern–Volmer equation demonstrated that FA-BSP-SA micelles decreased the fluorescence of BSA via static quenching. The measurement results of thermodynamic parameters (entropy change, enthalpy change, and Gibbs free energy) suggested that the binding between FA-BSP-SA and BSA was spontaneous in which Van der Waals forces and hydrogen bonding played major roles. The results from synchronous fluorescence, circular dichroism, and UV spectra also revealed that BSA conformation was slightly altered by decreasing α-helical contents. In addition, the antitumor effects in vitro of Dox@FA-BSP-SA micelles and the cellular uptake behavior of micelles in 4T1 cells were decreased after incubating with BSA.